Kit ELISA sandwich Insulin-like Growth Factor Binding Protein 5 (Hu IGFBP5) (human): quantitative assay of Hu IGFBP5 in serum, plasma or cell culture medium.
Kit ELISA sandwich Insulin-like Growth Factor Binding Protein 5 (Hu IGFBP5) (human): quantitative assay of Hu IGFBP5 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu IGFBP5.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Insulin-related growth factor binding proteins, or IGFBP, are a family of homologous proteins that have co-evolved with IGF. They not only serve as transport molecules for soluble IGFs, but also provide a level of regulation for the IGF signalling system. The physical association of IGFBPs with IGF influences the bioavailability of growth factors and their concentration and distribution in the extracellular environment. In addition, IGFBPs appear to have biological activity independent of IGFs. To date, seven IGFBPs have been described, each different in their tissue distribution, half-life, and modulation of IGF interactions with their receptors. For example, IGFBP1 is negatively regulated by insulin production. The IGFBP1 gene is expressed at a high level during foetal liver development and in response to nutritional changes and diabetes. It was suggested that IGFBP2 function as a chaperone, escorting IGF to their target tissues. It is expressed in several human tissues, including the foetal eye and the fetal brain. IGFBP3 is the most abundant IGFBP and is complexed with about 80% of serum IGFs. Both IGFBP3 and IGFBP4 are released by dermal fibroblasts in response to incision injuries. IGFBP5 is secreted by myoblasts and can play a key role in muscle differentiation.
Sensitivity
Sensitivity of dosage: 2 pg/ml.
Measurement range
Dose range: 1.1 ng/ml to 800 ng/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Samples
Sample type: Plasma, Serum, Surnatant (plasma volume, 50 μl; serum, 50 μl; supernatant, 100 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17165469 |
| Specifications |
| Accession number | P24593 |
| Dose range | 1.1 ng/ml to 800 ng/ml |
| Sensitivity of the dosage | 2 pg/ml |
| Calibration range | 2 ng/ml to 800 ng/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Growth Factors & Receivers |
| Type of sample | Plasma, Serum, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, IGF |
| Sufficient for | 5 x 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 3488 |
| Gene symbol(s) | IBP5 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | SAV-HRP, Floor, Adhesive Plate Covers, Wash pad, 96-well pre-coated plates, Chromogen, Biotinylated Detection Antibody, Dose Diluent Concentrate, Stop Solution |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | RUO |
| Research disciplines | Signal transduction |
| Synonym | IBP5 |
| Target | Human |
| Test time | 1 hour 20 minutes. |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4:45 a.m. |
Origin and customs
| Manufacturer ref. | EHIGFBP5X5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.